<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02433028</url>
  </required_header>
  <id_info>
    <org_study_id>SMSC_1_3</org_study_id>
    <nct_id>NCT02433028</nct_id>
  </id_info>
  <brief_title>Swiss Multiple Sclerosis Cohort-Study</brief_title>
  <acronym>SMSC</acronym>
  <official_title>Swiss Multiple Sclerosis Cohort-Study: A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cantonal Hospital of Aarau, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Hospital Lugano (EOC), Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Multiple Sclerosis Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The key aims of the Swiss Multiple Sclerosis Cohort-Study (SMSC) are

        1. To maintain a long-term cohort (&gt;10 years) representative of the MS population currently
           living in Switzerland. This requires effective measures to limit drop-outs and the
           continuous recruitment of MS patients and

        2. To conduct a systematic follow-up with standardized, high quality collection of clinical
           and magnetic resonance imaging (MRI) data, as well as body fluids.

      The significant heterogeneity within the diagnostic entity and phenotype of multiple
      sclerosis (MS) is incompletely understood. A central and necessary prerequisite of further
      advance is a sufficient amount of high quality clinical and paraclinical (imaging, body
      fluids) patient data.

      Nested projects will address specific research topics, and facilitate collaboration of the
      most qualified investigators within the group of SMSC investigators. The nested projects will
      focus on the:

        1. Development and validation of diagnostic and prognostic markers of spontaneous disease
           evolution and therapeutic response.

        2. Exploration of the safety and impact on long-term disability of existing and next
           generation MS treatments

        3. Individualized therapy: A number of highly active but potentially also harmful therapies
           have lately been established for the treatment of MS. To date, due to the lack of
           individual prognostic markers patients may not receive aggressive therapy due to safety
           concerns, or patients with benign disease may receive expensive and potentially harmful
           treatments without the need for it.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">January 2042</completion_date>
  <primary_completion_date type="Anticipated">January 2042</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in assessment of Expanded Disability Status Scale (EDSS)</measure>
    <time_frame>every 6 or 12 months, up to 10 years</time_frame>
    <description>assessment of Expanded Disability Status Scale</description>
  </primary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Multiple Sclerosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinically isolated Syndrome, Radiologically isolated syndrome, Multiple Sclerosis, Devic
        Syndrome
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. without immunomodulatory treatment (DMD) or

          2. starting a DMD

          3. already treated with Tysabri® or Gilenya®

          4. switching a DMD or indication for switching DMD.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Kuhle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jens Kuhle, MD</last_name>
    <phone>0041612652525</phone>
    <email>jens.kuhle@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vanessa Valleja, Dr.</last_name>
    <phone>004161556 5251</phone>
    <email>vanessa.valleja@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cantonal Hospital Aarau</name>
      <address>
        <city>Aarau</city>
        <state>AG</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lutz Achtnichts, MD</last_name>
      <phone>0041 62 838 94 69</phone>
      <email>lutz.achtnichts@ksa.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jaqueline Saxer</last_name>
      <email>jaqueline.saxer@ksa.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Berne</name>
      <address>
        <city>Berne</city>
        <state>BE</state>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Salmen, MD</last_name>
      <email>anke.salmen@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Monika Käser</last_name>
      <email>monika.kaeser@insel.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>BS</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Kuhle, MD</last_name>
      <phone>0041612652525</phone>
      <email>jens.kuhle@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Vanessa Valleja, Dr.</last_name>
      <phone>004161556 5251</phone>
      <email>vanessa.valleja@usb.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Geneva</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrice Lalive, MD</last_name>
      <phone>0041 22 379 46 98</phone>
      <email>patrice.lalivedepinay@unige.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ninon Seiko Horie, MD</last_name>
      <email>ninon.seiko.horie@hcuge.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cantonal Hospital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <state>SG</state>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Mueller, MD</last_name>
      <phone>0041 71 494 11 11</phone>
      <email>stefanie.mueller@kssg.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Hospital Lugano</name>
      <address>
        <city>Lugano</city>
        <state>TI</state>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Gobbi, MD</last_name>
      <phone>0041 91 811 69 21</phone>
      <email>claudio.gobbi@eoc.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Lausanne</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam Schluep, MD</last_name>
      <phone>0041 21 314 12 69</phone>
      <email>myriam.schluep@chuv.ch</email>
    </contact>
    <contact_backup>
      <last_name>Renaud Du-Pasquier, MD</last_name>
      <email>renaud.du-pasquier@chuv.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Univeristy Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Martin, Prof. Dr. MD</last_name>
      <email>roand.martin@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Magdalena Foege, Dr., MD</last_name>
      <email>magdalena.foege@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MS key phases of disease evolution</keyword>
  <keyword>MS New Treatment Options</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

